TriSalus Life Sciences, Inc. (TLSI) earnings
TLSI earnings moved a median of +1.08% by the close. Quarterly and annual TLSI reports and results, each read against the price at its own news timestamp. Back to the TLSI overview →
26 measured TLSI earnings events.
Where these TLSI earnings landedvs 26 measured TLSI earnings reactions
| Middle 50% of TLSI earnings reactions | -1.63% to +4.09% |
|---|---|
| Median reaction (to close) | +1.08% |
| Measured reactions | 26 |
Point-in-time · zero look-ahead
Half of the 26 TLSI earnings events with a measured close landed between -1.63% and +4.09%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q TriSalus Life Sciences, For: Sep 30 | SEC filing · Form 10-Q | -6.89% | +12.21% | |
| TriSalus Life Sciences Reports Third Quarter 2026 Results | Press release | -6.89% | +12.21% | |
| TriSalus Life Sciences to Host Third Quarter 2026 Financial Results Conference Call | Press release | -2.31% | -0.27% | |
| Form 10-Q TriSalus Life Sciences, For: Jun 30 | SEC filing · Form 10-Q | -3.85% | +13.56% | |
| TriSalus Life Sciences Reports Second Quarter 2026 Results | Press release | -3.85% | +13.56% | |
| TriSalus Life Sciences to Host Second Quarter 2026 Financial Results Conference Call | Press release | -1.74% | -0.23% | |
| Form 10-Q TriSalus Life Sciences, For: Mar 31 | SEC filing · Form 10-Q | -11.94% | -25.83% | |
| TriSalus Life Sciences Reports First Quarter 2026 Results Demonstrating Commercial and Clinical Progress for Facilitating Long-Term Growth | Press release | -11.94% | -25.83% | |
| TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call | Press release | +1.12% | -4.27% | |
| Form 10-K TriSalus Life Sciences, For: Dec 31 | SEC filing · Form 10-K | +0.53% | -5.00% | |
| TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call | Press release | -2.87% | -3.58% | |
| TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call | Press release | +0.00% | -0.64% | |
| Form 10-Q TriSalus Life Sciences, For: Jun 30 | SEC filing · Form 10-Q | -2.38% | +4.22% | |
| TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance | Press release | -2.38% | +4.22% | |
| TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call | Press release | — | +1.61% | |
| Form 10-K/A TriSalus Life Sciences, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.04% | |
| Form 10-Q TriSalus Life Sciences, For: Mar 31 | SEC filing · Form 10-Q | +0.99% | +1.39% | |
| TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance | Press release | +0.99% | +1.39% | |
| TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call | Press release | +0.00% | -1.93% | |
| Form 10-K TriSalus Life Sciences, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.24% | |
| Form NT 10-K TriSalus Life Sciences, For: Dec 31 | SEC filing · Form NT | +2.20% | +1.28% | |
| Form 10-Q TriSalus Life Sciences, For: Sep 30 | SEC filing · Form 10-Q | -1.09% | -12.83% | |
| TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call | Press release | — | -0.25% | |
| Form 10-Q TriSalus Life Sciences, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +3.70% | |
| TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call | Press release | — | +0.87% | |
| TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call | Press release | — | -0.72% |
Keep exploring
More TLSI: analyst actions → · SEC filings → · TLSI overview →